INSPIRE VETERINARY PARTNE-A (IVP)
US45784E2054 - Common Stock
Taking everything into account, IVP scores 1 out of 10 in our fundamental rating. IVP was compared to 108 industry peers in the Health Care Providers & Services industry. IVP may be in some trouble as it scores bad on both profitability and health. IVP does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year IVP has reported negative net income.
IVP had a negative operating cash flow in the past year.
1.2 Ratios
Looking at the Return On Assets, with a value of -88.14%, IVP is doing worse than 92.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -88.14% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-38.16%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IVP's Gross Margin of 19.47% is on the low side compared to the rest of the industry. IVP is outperformed by 63.55% of its industry peers.
The Profit Margin and Operating Margin are not available for IVP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
IVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVP has less shares outstanding
Compared to 1 year ago, IVP has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -2.78, we must say that IVP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.78, IVP is not doing good in the industry: 85.98% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.78 |
ROIC/WACCN/A
WACC7.54%
2.3 Liquidity
A Current Ratio of 0.18 indicates that IVP may have some problems paying its short term obligations.
With a Current ratio value of 0.18, IVP is not doing good in the industry: 95.33% of the companies in the same industry are doing better.
IVP has a Quick Ratio of 0.18. This is a bad value and indicates that IVP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.13, IVP is not doing good in the industry: 96.26% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.18 | ||
| Quick Ratio | 0.13 |
3. Growth
3.1 Past
IVP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.58%.
The Revenue has grown by 15.13% in the past year. This is quite good.
EPS 1Y (TTM)-146.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.6%
Revenue 1Y (TTM)15.13%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.21%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
IVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
IVP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INSPIRE VETERINARY PARTNE-A
NASDAQ:IVP (12/20/2024, 8:19:21 PM)
Premarket: 0.1878 +0 (+0.16%)0.1875
+0 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners1.33%
Inst Owner Change-36.06%
Ins Owners2.8%
Ins Owner Change0%
Market Cap6.07M
AnalystsN/A
Price TargetN/A
Short Float %0.74%
Short Ratio0.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.35 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-134.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.53
BVpS-0.1
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -88.14% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.47% | ||
| FCFM | N/A |
ROA(3y)-38.16%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 32.93% | ||
| Cap/Sales | 2.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.18 | ||
| Quick Ratio | 0.13 | ||
| Altman-Z | -2.78 |
F-Score3
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)540.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.13%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-99.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.73%
OCF growth 3YN/A
OCF growth 5YN/A